Clinical studies recruiting near Adelaide

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Phase 3 · Royal Adelaide Hospital-Haematology Clinical Trials Unit ( S · Merck Sharp & Dohme LLC · NCT06351631 Precision Medicine for Every Child With Cancer
Phase N/A · Women's and Children's Hospital · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Phase 1/Phase 2 · The Royal Adelaide Hospital · Lin BioScience, Inc · NCT05756322 Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 · SOCRU · SAPU NANO (US) LLC · NCT07369505 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · North Adelaide- Womens and Childrens Hospital · Princess Maxima Center for Pediatric Oncology · NCT05327894 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 · Royal Adelaide Hospital · Iksuda Therapeutics Ltd. · NCT05365659 An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase 1/Phase 2 · Southern Oncology Clinical Research Unit (SOCRU) · Pathios Therapeutics Pty Ltd · NCT06634849 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Royal Adelaide Hospital · Travere Therapeutics, Inc. · NCT06247085 Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · CMAX Clinical Research Pty Ltd · TRex Bio, Inc. · NCT06934252 The ARRC III Trial of Advanced Recovery Room Care (ARRC).
Phase N/A · Royal Adelaide Hospital · University of Adelaide · NCT05836285 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Women's and Children's Hospital-Adelaide · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Women's and Children's Hospital-Adelaide · National Cancer Institute (NCI) · NCT05691478 A Study of NHL907 in Healthy Adult Participants
Phase 1 · CMAX Clinical Research Pty Ltd · NeuHyll AUS Pty Ltd · NCT07580924 Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency
NA · Flinders · InnoVein · NCT04253301 A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Phase 1 · Cancer Research South Australia · Sun Pharma Advanced Research Company Limited · NCT07042100 Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NA · The Royal Adelaide Hospital · University of Melbourne · NCT04434807 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 6103 · Turning Point Therapeutics, Inc. · NCT03093116 A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid T
Phase 1 · Clinical Research South Australia (CRSA) · Vividion Therapeutics, Inc. · NCT06804824 Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · Women and Children's Hospital · University of California, San Francisco · NCT05009992 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Women's and Children's Hospital · Eli Lilly and Company · NCT07222332 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Nightingale Research · Eli Lilly and Company · NCT07369011 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Women's and Children's Hospital-Adelaide · Children's Oncology Group · NCT04322318 ROADMAP Clinical Trial
Phase 4 · Calvary Adelaide Private Hospital · University of Newcastle, Australia · NCT06771050 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · Royal Adelaide Hospital · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Flinders Medical Center · Gilead Sciences · NCT06051617 A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Se
Phase 1/Phase 2 · Investigational Site Number : 0360002 · Sanofi · NCT07215234 A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Soli
Phase 1 · Cancer Research South Australia · BeOne Medicines · NCT07181681 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Royal Adelaide Hospital · Boehringer Ingelheim · NCT07220083

Look up another city

Look up another condition